ALNY vs VSAT · P/E 76, rev $1.29B vs rev $4.64B
Alnylam Pharmaceuticals Inc (ALNY) versus ViaSat Inc (VSAT) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
ViaSat Inc (VSAT) is a communication equipment company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported VSAT revenue for 2026-03-31 was $4.64B. Net income was -$34.1M. Revenue was up 2.7% from 2025-03-31 to 2026-03-31. VSAT currently screens at market cap $8.82B.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. VSAT currently screens at market cap $8.82B.
Not investment advice. Open the ALNY and VSAT stock pages for the full models.
Not investment advice.